XRNCRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。XRN遺伝子サイレンサーは、XRN CRISPR/Cas9ノックアウトプラスミドとXRNDouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のXRNCRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
XRN CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
XRN1 CRISPR/Cas9 KOプラスミド (h) | sc-401910 | h | Gene Knockout | GFP | 0 | ||
XRN1 HDRプラスミド (h) | sc-401910-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
XRN1 Double Nickaseプラスミド (h) | sc-401910-NIC | h | Gene Knockout | Puromycin | 0 | ||
XRN1 Double Nickaseプラスミド (h2) | sc-401910-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
XRN1 CRISPR/Cas9 KOプラスミド (m) | sc-423993 | m | Gene Knockout | GFP | 0 | ||
XRN1 HDRプラスミド (m) | sc-423993-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
XRN1 Double Nickaseプラスミド (m) | sc-423993-NIC | m | Gene Knockout | Puromycin | 0 | ||
XRN1 Double Nickaseプラスミド (m2) | sc-423993-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
XRN2 CRISPR/Cas9 KOプラスミド (h2) | sc-411608-KO-2 | human | Gene Knockout | GFP | 0 | ||
XRN2 HDRプラスミド (h2) | sc-411608-HDR-2 | human | Homology Directed Repair | Puromycin | 0 | ||
XRN2 Double Nickaseプラスミド (h) | sc-411608-NIC | h | Gene Knockout | Puromycin | 0 | ||
XRN2 Double Nickaseプラスミド (h2) | sc-411608-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
XRN2 CRISPR/Cas9 KOプラスミド (m) | sc-423994 | m | Gene Knockout | GFP | 0 | ||
XRN2 HDRプラスミド (m) | sc-423994-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
XRN2 Double Nickaseプラスミド (m) | sc-423994-NIC | m | Gene Knockout | Puromycin | 0 | ||
XRN2 Double Nickaseプラスミド (m2) | sc-423994-NIC-2 | m | Gene Knockout | Puromycin | 0 |
XRN CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
XRN1 CRISPR Activationプラスミド (h) | sc-401910-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
XRN1 CRISPR Activationプラスミド (h2) | sc-401910-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
XRN1 Lentiviral Activation Particles (h) | sc-401910-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
XRN1 Lentiviral Activation Particles (h2) | sc-401910-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
XRN1 CRISPR Activationプラスミド (m) | sc-423993-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
XRN1 CRISPR Activationプラスミド (m2) | sc-423993-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
XRN1 Lentiviral Activation Particles (m) | sc-423993-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
XRN1 Lentiviral Activation Particles (m2) | sc-423993-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
XRN2 CRISPR Activationプラスミド (h) | sc-411608-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
XRN2 CRISPR Activationプラスミド (h2) | sc-411608-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
XRN2 Lentiviral Activation Particles (h) | sc-411608-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
XRN2 Lentiviral Activation Particles (h2) | sc-411608-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
XRN2 CRISPR Activationプラスミド (m) | sc-423994-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
XRN2 CRISPR Activationプラスミド (m2) | sc-423994-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
XRN2 Lentiviral Activation Particles (m) | sc-423994-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
XRN2 Lentiviral Activation Particles (m2) | sc-423994-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |